FDA Clearance Tracker · P030017-S377
Precision Spinal Cord Stimulator (SCS) Systems
Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 21, 2026
Approved
Time to decision
541 days
Received Jul 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030017-S377
- Device name
- Precision Spinal Cord Stimulator (SCS) Systems
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Jul 29, 2024
- Decided
- Jan 21, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P030017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the following changes related to the OR cables and extensions: 1) an alternate manufacturing site (i.e., Jiangyin SINBON Electronics Co. Ltd., FDA Establishment Identifier 3007616088), 2) dimensional changes, 3) change of material for two polyurethane components (i.e., strain relief and cable jacket) to a trademarked thermoplastic polyurethane (i.e., IROGRAN A75E 5040), and 4) removal of a duplicative cleaning step.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.